Abstract
Switzerland has adopted a policy of international exhaustion of trade marks and copyrights. Parallel imports of patented goods, however, are prohibited. Frustrated by high prices and drug expenditures, a number of payer and consumer organisations are seeking to adapt the patent law, so that parallel imports of patented goods would become legal.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
European Observatory on Health Care Systems (2000): Health Systems in Transition: Switzerland, Page 28
European Observatory on Health Care Systems (2000): Health Systems in Transition: Switzerland
European Observatory on Health Care Systems (2000): Health Systems in Transition: Switzerland
Binder T. (2007), Pharmamarkt Schweiz 2006, IMS Health GmbH, Pages 7, 18
Binder T. (2007), Pharmamarkt Schweiz 2006, IMS Health GmbH, Page 18
Binder T. (2007), Pharmamarkt Schweiz 2006, IMS Health GmbH, Page 18
Bundesgesetz über Arzneimittel und Medizinprodukte, HMG, Abs 14
Binder T. (2007), Pharmamarkt Schweiz 2006, IMS Health GmbH, Page 18
Binder T. (2007), Pharmamarkt Schweiz 2006, IMS Health GmbH, Page 18
International Trade Administration, U.S. Department of Commerce (2004), Pharmaceutical Price, Controls in OECD Countries Implications for U.S. Consumers, Pricing, Research and Development, and Innovation, p. 23
Parallelimporte und Patentrecht, Bericht des Bundesrates vom 8. Mai 2000 in Beantwortung der Anfrage der Kommission für Wirtschaft und Abgaben des Nationalrats (WAK) vom 24. Januar 2000
The European Court of Justice (1999), Judgement of the court in Case C-173/98
The European Court of Justice (1996), Judgement of the court in Case C-355/96
Larsson, P (1999). Parallel Imports: A Swedish Study on Effects of the Silhouette Ruling
S. Vaterlaus (2004), Warum erodieren Parallelimporte die Preisinsel Schweiz nicht stärker? Ermittlung der Rolle der geistigen Schutzrechte anhand exploratorischer Expertengespräche
i.E. the official language of the canton, where the product is sold
Plaut & Frontier Economics, 2002, Erschöpfung von Eigentumsrechten: Auswirkungen eines Systemwechsels auf die Schweizerische Volkswirtschaft
Kanavos P. and Costa-Font J (2005), Pharmaceutical parallel trade in Europe: stakeholder and competition effects, Economic Policy October 2005, p 778
Kanavos P. and Costa-Font J (2005), Pharmaceutical parallel trade in Europe: stakeholder and competition effects, Economic Policy October 2005, p 778
Kanavos P. and Costa-Font J (2005), Pharmaceutical parallel trade in Europe: stakeholder and competition effects, Economic Policy October 2005, p 778
M. Ganslandt, K.E. Maskus (2004), J. of Health Economics 23 (dy2004) 1035–1057, p.1049
Binder T. (2007), Pharmamarkt Schweiz 2006, IMS Health GmbH, Pages 7, 18
International Trade Administration, U.S. Department of Commerce (2004), Pharmaceutical Price, Controls in OECD Countries Implications for U.S. Consumers, Pricing, Research and Development, and Innovation, p. 23
Rights and permissions
Copyright information
© 2008 Birkhäuser Verlag AG
About this chapter
Cite this chapter
(2008). How should Switzerland proceed with its legislation on the exhaustion of patent rights?. In: Parallel Imports of Pharmaceuticals. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8589-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8589-7_8
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8588-0
Online ISBN: 978-3-7643-8589-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)